Therapeutic Potential of Morus alba, Cinnamomum verum, and Trigonella foenum-graecum in Type 2 Diabetes: A Narrative Review

Type 2 diabetes mellitus (T2 DM) is one of the most conventional metabolic disorders worldwide, which is initially powered by asymmetrical lifestyle, unhealthy eating, and growing urbanisation. As a chronic state characterised by insulin prevention and weak glucose metabolism, T2 DM creates a significant health, social, and economic burden. Although conventional pharmaceutical treatments play an important role in the control of glycemia, they are often associated with side effects, expenditure limitations, and the patient's noncompliance. In recent years, the interest in exploring alternatives and supplemental therapy from medicinal plants, especially antidiabetic ones, has been increasing. This descriptive review investigates the therapeutic possibilities of three traditional herbs—Trigonella foenum-graecum (fenugreek), Cinnamomum verum (real cinnamon), and Morus alba (white mulberry)—under the management of T2DM. Each of these botanicals has a chronic history in the traditional medical system and shows hopeful hypoglycemic, antioxidant, and insulin-sensitive effects based on emerging preclinical and clinical evidence. Despite their enthusiastic pharmacological profile, the challenges of extracting the extract, determining effective dose, organic availability, and long-term security are continuing. This review emphasises the requirements of strict, well-planned clinical trials and pharmacodynamic studies to verify the effectiveness and security of these herbal interventions. Finally, the goal of this study is to catalyse more scientific investigation on plant-based accessory therapy for T2DM and to encourage more integrated and overall methods for diabetes care.